Potential Penetration of Topical Ranibizumab (Lucentis) in the Rabbit Eye

Eye - United Kingdom
doi 10.1038/eye.2011.225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) vs Bevacizumab (Avastin)

Ocular Surface
Ophthalmology
2012English

Intravitreous Ranibizumab (Lucentis) for Radiation Maculopathy

Archives of Ophthalmology
2010English

Ranibizumab and the Eye

CMAJ
Medicine
2011English

Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)

BMC Geriatrics
GerontologyGeriatrics
2010English

A Rabbit Dry Eye Model Induced by Topical Medication of a Preservative Benzalkonium Chloride

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Ranibizumab (Lucentis®) Intravítreo en El Tratamiento De Membrana Neovascular Coroidea Secundaria a Coroidopatía Punctata Interna

Archivos de la Sociedad Espanola de Oftalmologia
Ophthalmology
2010English

Melanoma (Sarcoma) of the Eye in a Syphilitic Rabbit

Journal of Experimental Medicine
MedicineAllergyImmunology
1926English

Ocular Penetration of Cyclosporin A. III: The Human Eye.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1990English

Topical Curcumin Nanocarriers Are Neuroprotective in Eye Disease

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy